破壁融合，共析流式产业升级新生态|ACCSI2025首届流式产业发展论坛在沪圆满召开

Core Viewpoint - The first Flow Cytometer Industrialization Development Forum was successfully held in Shanghai, focusing on technological advancements and the current state of the flow cytometry industry, discussing new trends in industry development [1][2]. Group 1: Forum Overview - The forum attracted over 1,800 participants from various sectors, including government leaders, experts, instrument manufacturers, testing institutions, and investors, marking a record scale for the event [2]. - The forum was a highlight of the 18th Annual Conference of China Scientific Instruments (ACCSI 2025), which aims to promote effective communication among various stakeholders in the scientific instrument industry [31]. Group 2: Industry Development - The flow cytometry industry has made significant progress in market size, competitive landscape, technological innovation, and application field expansion, moving beyond traditional research and clinical testing to new areas such as bioengineering, environmental science, and food science [4][5]. - The emergence of various popular flow cytometry technologies is driving the industry into a new round of transformation, raising questions about achieving a win-win situation between local brand development and the localization of imported brands [5]. Group 3: Key Presentations - Keynote presentations were delivered by industry experts, including advancements in nano-flow cytometry technology for extracellular vesicle detection, which allows for high-resolution analysis of particles as small as 40 nm [10][11]. - The development of next-generation high-parameter flow cytometers represents a significant technological advancement, providing high-quality biological data to address key societal challenges in health, food, energy, and environment [12][13]. - The challenges and necessary innovations in the flow cytometry antibody industry were discussed, highlighting the success of companies like BioLegend, which achieved over $400 million in sales [14][15]. Group 4: Roundtable Discussion - A roundtable discussion featured nearly 50 experts discussing the opportunities and challenges in the flow cytometry industry, including the impact of AI and machine learning on future developments [21][23]. - The discussion emphasized the importance of product application in real-world scenarios and the potential for domestic brands to replace imported ones while addressing quality and functionality differences [23].